Matches 1 - 50 out of 108 1 2 3 >


Match Document Document Title
DE102019003442A1 Use of low molecular weight glycosidically bound terminal galactosides and fucosides for binding toxins acting as galectin in the treatment of poisoning, especially in the case of poisoning with ricin  
The invention includes the use of low molecular weight glycosidic compounds with terminal D-galactose and L-fucose in the context of the treatment of poisoning with ricin. The compounds found form...
DE202019005475U1 A food composition comprising 2'-fucosyl lactose for enhancing the gastrointestinal barrier  
Food composition comprising 2'-Fucosyllactose (2'FL) and Lacto-N-neotetraose (LNnT), wherein 2'FL is present in an amount of 0.005-5 g / L of the composition, and wherein LNnT is present in an...
DE202016008919U1 Compositions for use in the prevention or treatment of gastrointestinal infection / inflammation in infants or young children  
Food composition comprising only 2'-fucosyllactose (2-FL) as fucosylated oligosaccharide and only lacto-N-neotetraose (LNnT) as N-acetylated oligosaccharide, the ratio of fucosylated...
DE202011111124U1 Polymorph of a tretrasaccharide containing N-acetyllactosamine  
A polymorph of Galpβ1-4GlcNAcpβ1-3Galpβl-4Glc (LNnT), characterized in that it has X-ray powder diffraction reflections based on a measurement using CuKa radiation, at a 2Θ angle of 20.32 ± 0.20,...
DE202013012839U1 New polymorphs from LNnT  
A crystalline LNnT polymorph IV, characterized in that it shows X-ray powder diffraction reflections based on a measurement using CuKa radiation at 2Θ angles of 8.16 and 15.41, more preferably at...
DE202013012829U1 Improving the stability and purity and increasing the bioavailability of human milk oligosaccharides or precursors or mixtures thereof  
A spray-dried oligosaccharide from human milk (HMO) or a spray-dried HMO mixture with improved stability after prolonged storage at temperatures above 25 ° C and produced by a process comprising...
DE202013012827U1 Improving the stability and purity and increasing the bioavailability of human milk oligosaccharides or precursors or mixtures thereof  
Spray-dried neutral oligosaccharide from human milk (HMO) or a spray-dried neutral HMO mixture with improved stability after prolonged storage at temperatures above 25 ° C., which is produced by a...
DE202014011399U1 Neutral human milk oligosaccharides (HMOs) from microbial fermentation  
A concentrate of a neutral human milk oligosaccharide (HMO) product containing a desired HMO in a concentration of ≥ 100 g / l and one or more impurities in an aqueous solution, the HMO product...
DE102018000033A1 Process for accelerated general and skin regeneration and wound healing  
Method for accelerated wound healing and skin regeneration is characterized that quark or one or more of its ingredients with tomato or one or more of its ingredients be administered in combination.
DE60217319T3 USE OF A PREBIOTIC COMPOSITE FOR REDUCING THE FLAMMABLE PROCESS AND ABORTIONAL ACTIVATION OF UNSPECIFIC IMMUNO PARAMETERS  
The present invention relates to a composition comprising prebiotic (prebiotic adjuvant) for decreasing inflammatory process by improving the homeostasis of non-specific immune parameters and of...
DE102017110935A1 Anti-inflammatory high-purity oligosaccharides  
The present invention relates to a high-purity oligosaccharide for use as a pharmaceutical as well as to a pharmaceutical composition comprising the high-purity oligosaccharide of the present...
DE202018101105U1 Hygienic agent with active ingredient for lowering the pH of the vagina and / or the external genitals  
The hygienic agent (1) having an active substance for lowering the pH of the vagina and / or the external genitalia, where the active substance contains the crystalline lactic acid or its salts...
DE19861497B3 Babies' food and their use for the promotion of human colorectal flora  
According to the invention, baby food containing at least two different, soluble carbohydrates is provided. This baby food is characterized by the fact that the carbohydrates consist of a...
DE19861508A1 Carbohydrate mixture  
According to the invention, a carbohydrate mixture is provided for dietary diets and pharmaceuticals containing at least two different, soluble carbohydrates. This carbohydrate mixture is...
DE60122570T3 FOOD COMPOSITION FOR IMMUNE DISEASE  
A nutritional composition is described for prevention or treatment of an immune condition. The composition includes at least vitamin E, vitamin C, vitamin B6, folic acid, vitamin B12, copper,...
DE602004006133T3 NEW GALACTOOLIGOSACCHARIDZUSAMMENSETZUNG AND PREPARATION THEREOF  
Novel strains of Bifidobacterium hifidum capable of producing a novel galactosidase enzyme activity that converts lactose to a novel mixture of galactooligosaccharides. The mixture of...
DE102012019029A1 Pharmaceutical formulation prepared by dissolving adjuvant in polyethylene glycols, useful for administration of active multiple charged anions e.g. heparin or its derivative, oligosaccharide or polysaccharide and nucleic acid sequence  
Oral pharmaceutical formulation prepared by dissolving an adjuvant in polyethylene glycols or their derivatives, is claimed.
DE602004006258T3 Food composition containing indigestible Transgalaktooligosaccharide and digestible galactose saccharide  
The present invention provides a method and composition for the treatment and/or prevention of respiratory tract infection and/or respiratory tract infection disease, said method comprising orally...
DE60114778T3 TREATMENT OF INFECTIONS IN ANIMALS  
The present invention relates to the use of a non-digestible carbohydrate in the manufacture of a composition for treating or preventing pathogenic bacteria in the large intestine of a pet animal....
DE69511374T3 NEW AND IMPROVED AMINOGLYKOSIDFORMULIERUNG AS AEROSOL  
An aminoglycoside formulation for delivery by aerosolization. The concentrated aminoglycoside formulation containing an efficacious amount of aminoglycoside able to inhibit 95-100% of susceptible...
DE19836339B4 carbohydrate blend  
Carbohydrate mixtures for dietetic foods and pharmaceuticals containing at least two different soluble carbohydrates, wherein the soluble carbohydrates consist of a carbohydrate component A...
DE60002331T3 COMPOSITIONS FOR THE CREATION AND BEHALTUNG ENERGY AND MENTAL WACHSAMHEIT  
The present invention relates to compositions which provide an onset and steady maintenance of energy to the consumer, as well as kits comprising the compositions and methods of using the...
DE69734841T3 Compositions vegetable carbohydrate base as dietary supplements  
Compositions of plant carbohydrates for dietary supplements and nutritional support for promotion and maintenance of good health. Defined nutritionally effective amounts of one to eleven essential...
DE102008020797A1 Skin cream useful for e.g. treatment and/or prophylaxis of dry skin and/or skin damage in diabetic foot, comprises saccharide e.g. mannobiose, polysaccharide e.g. dextran, multivalent alcohol e.g. glycerol, urea, polycation and carrier  
Skin cream comprises at least one saccharide, at least one polysaccharide, at least one multivalent alcohol, urea, at least one polycation and at least one pharmaceutically or cosmetically...
DE69802413T3 Lactobacilli FOR INCREASE OF MINERALS BY INTESTINAL CELLS ABSORPTION  
A method for increasing or facilitating the absorption of minerals from the diet. A nutritional composition which contains lactobacilli is enterally administered to a mammal. The nutritional...
DE69839355T2 Ophthalmic compositions containing Galaktomannanpolymere and borate  
The present invention is directed to ophthalmic compositions containing a gelling amount of a combination of galactomannan polysaccharides and borates. The compositions gel or partially gel upon...
DE60133581T2 Of Lactobacillus casei KE01 STRAIN PROBIOTIC DERIVED COMPOUNDS  
Probiotic compositions are provided that comprise Lactobacillus casei strain KE01 having ATCC accession number PTA-3945. The disclosed probiotic compositions are useful in inhibiting enteric...
DE69839046T2 USING a factor a inhibitory oligosaccharides WITH A anticoagulant MEANS FOR TREATING ARTERIAL THROMBOSIS  
The invention relates to the use of direct or indirect selective inhibitors of factor Xa acting via antithrombin III, alone or in combination with one or more compounds with anti-platelet...
DE60224541T2 USE OF DC-SIGN AND DC-SIGN-R FOR INHIBITING A VIRUS INFECTION WITH HEPATITIS C  
This invention provides a method of inhibiting HCV infection of a cell susceptible to HCV infection which comprises contacting the cell with an amount of a compound effective to inhibit binding of...
DE60131838T2 USE OF GLUTAMATE or glutamic FOR PREVENTING OR hyperpermeability unwanted PERMEABILITY OF INTESTINAL WALL  
The present invention relates to the use of glutamic acid for the preparation of a nutritional preparation that is intended for use for the treatment or prevention of excess or undesired...
DE60124715T2 USE OF oligosaccharides TO STIMULATE THE PRODUCTION OF BETA-ENDORPHIN  
Use of at least one oligosaccharide comprising 2-6 sugars and containing at least 2 galactose groups, preferably side groups, and especially at the end of the chain, or such oligosaccharide-...
DE69938241T2 COMPOSITIONS FOR TREATING BY C. difficile Toxin B CAUSED BY FALL DISEASES (CDAD)  
This invention relates to prevention and/or treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD), pseudomembranous colitis (PMC) and other...
DE69936740T2 Oligosaccharides and probiotics containing preparation  
A composition (I) having a health-promoting action, in particular for the prevention and/or treatment of disorders of the digestive tract, contains one or more probiotics and one or more...
DE10226203B4 Condensed palatinose, processes for their preparation and their use  
The invention relates to a novel palatinose condensation product which is obtained by condensing the disaccharide palatinose in a molten mass of palatinose, water and an organic acid.
DE60035355T2 IMMUNE REINFORCING LINKS  
The invention provides an immunopotentiating composition and to a composition accelerating the production of interferon- gamma , both comprising lactosuclose as an active ingredient. In...
DE60034898T2 An antiallergic composition comprising oligosaccharides and a saponin or a basic amino acid includes, for topical administration or inhalation  
The use of compositions containing a polysaccharide (I) having 3 - 5 oside units and at least one D-galactose unit linked by an alpha -1-6 bond to a sucrose unit, and a second compound (II) that...
DE60220182T2 SOFT DRINKS REPLACEMENT  
One aspect of the present invention relates to a liquid edible composition comprising pectin and oligosaccharides, wherein the weight ratio oligosaccharides to pectin exceeds 0.25. Another...
DE60220084T2 THE USE OF A SPECIFIC DOSE OF SODIUM Fondaparinux FOR THE TREATMENT OF ACUTE CORONARY SYNDROME  
The invention relates to the use of a dose of 2.5 mg of the pentasaccharide methyl O-(2-deoxy-2-sulfoamino-6-O-sulfo- alpha -D-glucopyranosyl)-(1-4)-O-( beta -D-glucopyranosyl uronic...
DE602004006258T2 Food composition containing indigestible oligosaccharides  
The present invention provides a method and composition for the treatment and/or prevention of respiratory tract infection and/or respiratory tract infection disease, said method comprising orally...
DE60219653T2 PHARMACEUTICAL COMPOSITION WITH CHITO-OLIGOMERS  
Compositions are provided comprising chito-oligomers obtainable from chitin, comprising oligomers of N-acetyl glucosamine (NAG) and glucosamine, wherein at least 50% of the oligomers have a chain...
DE602004006133T2 NEW GALACTOOLIGOSACCHARIDZUSAMMENSETZUNG AND PREPARATION THEREOF  
Novel strains of Bifidobacterium hifidum capable of producing a novel galactosidase enzyme activity that converts lactose to a novel mixture of galactooligosaccharides. The mixture of...
DE60126994T2 STABILIZATION OF RADIO MARKETING COMPOSITIONS WITH A HYDROPHILIC thioether OR A HYDROPHILIC 6-HYDROXY-chroman  
Radiopharmaceutical compositions which are stabilized by addition of a hydrophilic 6-hydroxy-chroman derivative, or a mixture of a hydrophilic thioether and a hydrophilic 6-hydroxy-chroman derivative.
DE60217319T2 USE OF A COMPOSITION WITH A prebiotic MEANS FOR REDUCING INFLAMMATORY PROCESS AND THE ABNORMAL ACTIVATION nonspecific IMMUNE PARAMETERS  
The present invention relates to a composition comprising prebiotic (prebiotic adjuvant) for decreasing inflammatory process by improving the homeostasis of non-specific immune parameters and of...
DE60122570T2 FOOD COMPOSITION FOR IMMUNE DISEASE  
A nutritional composition is described for prevention or treatment of an immune condition. The composition includes at least vitamin E, vitamin C, vitamin B6, folic acid, vitamin B12, copper,...
DE69934325T2 COMPOSITIONS FOR INCREASING THE DARMABSOPTION FATS  
This invention provides a composition and method for increasing fat absorption from the intestine by increasing the amount of lysophosphatidylcholine in the intestine. The composition comprises...
DE69835201T2 neoglycoproteins  
Polyamide conjugates comprising either (a) a xenoantigenic group; or (b) a biologically active group and a macromolecular, macro- or microscopic entity; bound to a polyamide backbone, processes...
DE60211632T2 Using Cyclotetrasaccharide to increase the "active oxygen eliminating activity"  
A reduction inhibitory agent for active oxygen eliminating activity which comprises cyclotetrasaccharide, i.e., cyclo{→6}-α -D-glucopyranosyl-(1 → 3)- α -D-glucopyranosyl-(1 → 6)- α...
DE69934046T2 BETA-Glucooligosaccharides TO SPEED OF CALCIUM RECORDING  
Disclosed is a calcium assimilation accelerator which contains a beta -glucooligosaccharide as an active ingredient, a calcium-supplementing diet which contains a beta -glucooligosaccharide and a...
DE60124030T2 Treatment of rumen acidosis with Amylasehemmern  
Inhibitors of rumen bacterial alpha-amylase and/or alpha-glucosidase are useful in the preparation of medicaments for the curative, palliative and prophylactic treatment of rumen acidosis and...
DE69834256T2 METHOD AND COMPOSITION FOR TREATING DELAYED ALLERGIC REACTIONS AND INFLAMMATORY DISEASES  
A method of treating a mammalian patient suffering from or prone to a condition characterized by late phase allergic reactions, airway hyperresponsiveness or inflammatory reactions, e.g., asthma,...

Matches 1 - 50 out of 108 1 2 3 >